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Abstract
Background: In order to promote infection, the blood-borne parasite Trypanosoma brucei releases factors that upregulate
arginase expression and activity in myeloid cells.
Methodology/Principal findings: By screening a cDNA library of T. brucei with an antibody neutralizing the arginase-
inducing activity of parasite released factors, we identified a Kinesin Heavy Chain isoform, termed TbKHC1, as responsible
for this effect. Following interaction with mouse myeloid cells, natural or recombinant TbKHC1 triggered SIGN-R1 receptor-
dependent induction of IL-10 production, resulting in arginase-1 activation concomitant with reduction of nitric oxide (NO)
synthase activity. This TbKHC1 activity was IL-4Ra-independent and did not mirror M2 activation of myeloid cells. As
compared to wild-type T. brucei, infection by TbKHC1 KO parasites was characterized by strongly reduced parasitaemia and
prolonged host survival time. By treating infected mice with ornithine or with NO synthase inhibitor, we observed that
during the first wave of parasitaemia the parasite growth-promoting effect of TbKHC1-mediated arginase activation
resulted more from increased polyamine production than from reduction of NO synthesis. In late stage infection, TbKHC1-
mediated reduction of NO synthesis appeared to contribute to liver damage linked to shortening of host survival time.
Conclusion: A kinesin heavy chain released by T. brucei induces IL-10 and arginase-1 through SIGN-R1 signaling in myeloid
cells, which promotes early trypanosome growth and favors parasite settlement in the host. Moreover, in the late stage of
infection, the inhibition of NO synthesis by TbKHC1 contributes to liver pathogenicity.
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Introduction
The protozoan flagellate parasite Trypanosoma brucei is responsible
for the diseases human sleeping sickness and nagana in cattle. In
experimental murine models, the host immune response to this
blood-borne pathogen involves antibody production against the
Variant Surface Glycoprotein (VSG), as well as interferon-c (IFN-c)-
mediated activation of macrophages/myeloid cells into cells of the
M1 phenotype. These engulf opsonized parasites and synthesize
factors that interfere with trypanosome growth including tumor
necrosis factor-a (TNF). However, uncontrolled IFN-c-induced
immune responses including TNF and NO production as the
infection persists induce tissue pathogenicity and death of the host
[1–5]. Induction of IL-10 can attenuate the IFN-c/M1 response and
hereby enables prolonged survival of T. brucei-infected mice [6–8].
Only few T. brucei-derived immunomodulatory factors have
been identified. These include the glycosylphosphatidylinositol
anchor of VSG, CpG oligodeoxynucleotides and the trypanosome
suppressive immunomodulating factor (TSIF) which have been
found to induce TNF- and NO-secreting M1 cells [9–12]. Factors
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inducing M1 cells favor the control of parasite development in the
early stage of infection, but their continuous release in the late
stage of infection can sustain inflammation responsible for tissue
pathogenicity. Components found in the culture medium of T.
brucei have also been shown to affect immune cells of the host. In
particular, factors released by the parasite promote the degrada-
tion of L-arginine through increase of arginase activity in
macrophages/myeloid cells, and antagonize NO synthases
(NOS)-mediated conversion of L-arginine into NO in infected
mice. Arginase induction appears to attenuate the innate response
at the early stage of infection, and likely contributes to the
synthesis of polyamines and the trypanosome anti-oxidant
trypanothione, known to promote trypanosome growth and
colonization of the host [5,13–15]. We have identified TbKHC1,
a kinesin heavy chain isoform, as a factor released by T. brucei to
trigger host arginase-1 activity for promotion of its own growth in
the host. Although arginase-1 expression is commonly associated
with alternatively activated myeloid cell (M2) functions, TbKHC1-
induced arginase-1 was independent of IL-4Ra signaling but relied
on a SIGN-R1 receptor-dependent IL-10 secretion.
Results
A T. brucei kinesin heavy chain induces arginase activity
in myeloid cells
T. brucei parasites were found to induce arginase activity in
myeloid cells from non-infected mice (Fig. 1A). This induction was
maintained when myeloid cells and trypanosomes were separated
by a cell-retaining insert, indicating that soluble components from
trypanosomes were involved (Fig. 1A). Parasite-released factors
(PRF) were prepared under conditions leading to no detectable
trypanosome death. PRF induced arginase activity, and this effect
was abolished by heat-treatment (Fig. 1A). Monoclonal antibodies
raised against T. brucei PRF (2C12) inhibited arginase activity
induced by PRF, whereas other antibodies from the same
hybridoma fusion (2A3, 2C6, 4B5) or of irrelevant specificity
(5F6, 4J5) had no effect (Fig. 1B). The PRF fraction eluted after
binding to a 2C12 antibody-based affinity column retained full
arginase-inducing activity, confirming that this activity was directly
targeted by 2C12 (Fig. 1C).
The 2C12 antibody was used to screen a cDNA expression
library and identify the T. brucei arginase-inducing protein. Among
the 6 positive clones identified, 5 encoded fragments of the same
putative kinesin heavy chain isoform (geneDB accession number
Tb927.6.4390), which we termed TbKHC1 for T. brucei kinesin
heavy chain 1 (Fig. S1in Text S1). The protein N-terminal domain
contained the highly conserved kinesin motor domain with a
typical ATP binding site. The region targeted by 2C12 antibody
located downstream from the motor domain and was character-
ized by a predicted coiled structure (Fig. S1 in Text S1).
TbKHC1 knock-out (KO) parasites were generated from wild-
type (WT) T. brucei. In contrast to PRF from WT parasites, PRF
from TbKHC1 KO parasites did not trigger arginase activity in
myeloid cells from non-infected mice (Fig. 1C).
TbKHC1 partially localizes in the endocytic compartment
and is released from the parasite
Pleomorphic trypanosomes, differentiating in the bloodstream
from proliferative slender forms into quiescent stumpy forms, can
induce long-standing infection in mammals and perform cyclical
transmission in tsetse flies while differentiating into procyclic
forms. In contrast, monomorphic trypanosomes, resulting from
prolonged cultivation in vitro, are unable to develop long-lasting
infection and cyclical transmission. The TbKHC1 gene was found
to be expressed preferentially in slender bloodstream forms
(Fig. 2A,B). Parasite immunolabeling with both monoclonal
2C12 and polyclonal antibodies generated against recombinant
TbKHC1 (rTbKHC1) vanished in TbKHC1 KO parasites or
RNAi-mediated TbKHC1 knock-down (KD) parasites, while it
increased in trypanosomes over-expressing TbKHC1 (Fig. 2A–D),
confirming that TbKHC1 is the genuine target of the anti-PRF
2C12 antibody.
Both antibodies revealed a scattered protein distribution
primarily between the kinetoplast and the nucleus (Fig. 2C,D).
TbKHC1 partially co-localized with tomato lectin, which detects
linear chains of poly-N-acetyllactosamine typical of the endocytic
compartment [16] (Fig. S2A in Text S1). However, TbKHC1 did
not bind to tomato lectin in affinity chromatography assay (Fig.
S2B in Text S1), suggesting that TbKHC1 is not an endocytic
component. Moreover, a fraction of TbKHC1 was reproducibly
found in the culture medium of parasites, as revealed by
immunoprecipitation of detergent-free supernatants from meta-
bolically 35S-labelled T. brucei (Fig. 2E). In these experiments,
trypanosome lysis was unlikely as the supernatants did not contain
any evidence of the cytoplasmic markers actin [17] or protein
disulfide isomerase 2 [18], but did contain enolase, a protein
released from trypanosome-related parasites such as Leishmania
[19] (Fig. 2E). TbKHC1 immunoprecipitated from the trypano-
some supernatant did not associate with other 35S-labelled proteins
(Fig. 2E), as could have been expected in case of release as a
complex.
IL-10 and mannose regulate TbKHC1-induced arginase
activity
We screened for pathways altering the levels of PRF-induced
arginase activity in myeloid cells. Co-incident with the induction of
arginase activity, PRF induced myeloid cells to express the
regulatory cytokine IL-10 (Fig. 3A). The arginase activity induced
by PRF was inhibited by neutralizing anti-IL-10 antibody and by
D-mannose, but not by D-galactose (Fig. 3B).
Author Summary
From the first invasive step onwards, African trypanosomes
can efficiently undermine the protective immune response
of their mammalian host to favor their survival within the
host and successful transmission by its vector, the tsetse
fly. Identifying the parasite factors affecting the protective
immune response is thus critical to detail the immune
evasion mechanisms of these organisms. We report here
that during acute infection, a Trypanosoma brucei protein
named Kinesin Heavy Chain 1 (TbKHC1) sustains the
development of the first (most prominent) peak of
parasitaemia in the blood and its control by the host.
Mechanistically, TbKHC1 was found to interact with the
SIGN-R1 molecule at the surface of immune cells. Hereby,
TbKHC1 modulates arginine/NO metabolism in immune
cells towards the production by the host of nutrients
(polyamines) required for parasite growth via an IL-10-
dependent induction of arginase 1 and down-regulation of
iNOS activities. Consequently, IL-10/arginase 1 producing
immune cells are impaired in their capacity to destroy the
parasite, favouring parasite settlement. Moreover, in the
late stage of infection, the inhibition of NO synthesis by
TbKHC1 increases liver pathogenicity that contributes to
compromised host survival. Thus, targeting TbKHC1 may
benefit the host protective immunity against T. brucei
parasite.
Trypanosoma brucei Kinesin
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rTbKHC1 mimicked the arginase-inducing effect of PRF,
including its inhibition by 2C12, anti-IL-10R antibodies and D-
mannose (Fig. 3C). The increased arginase activity induced by
rTbKHC1 associated with increased expression of the Arg1, but
not Arg2 gene, as well as impaired expression of the iNOS gene
(Fig. 3D). Activation of myeloid cells by rTbKHC1 also resulted in
increased expression of the IL-10 gene (Fig. 3D) and protein
(Fig. 3C), the latter being inhibited by the 2C12 antibody and D-
mannose. Thus, TbKHC1 interaction with myeloid cells involved
a mannose-sensitive event triggering the synthesis of IL-10,
resulting in enhanced Arg1 gene expression and activity, and
inhibition of iNOS expression.
Although arginase-1 expression is commonly associated with
alternatively activated myeloid cell (M2) functions, rTbKHC1 did
not trigger Il4 and Il13 gene expression in myeloid cells from WT
mice (Fig. 3D). Moreover, the induction of Arg1 and Il10 genes by
rTbKHC1 was conserved in IL-4Ra KO mice (Fig. 3E), excluding
that IL-10 synergistically enhanced IL-4Ra-induced Arg1 expres-
sion as observed in M2 cells [20,21]. Accordingly, rTbKHC1 did
not trigger the expression of M2-associated genes characteristic of
African trypanosome infection [22] (Fig. 3F). We also addressed
whether the induction of Arg1 by rTbKHC1 required IL-6 and G-
CSF in combination with IL-10 [23]. rTbKHC1 only induced Il6
gene expression (Fig. 3D). This expression was not affected
following addition of anti-IL-10R antibody that inhibited the
induction of arginase activity by rTbKHC1 (Fig. 3G), indicating
that IL-10 induced by TbKHC1 is the main trigger of Arg1
expression in myeloid cells.
Figure 1. Induction of myeloid cell arginase activity by T. brucei PRF. Arginase activity was determined in myeloid cells from non-infected
mice incubated with (A) WT parasites separated or not by an insert, or WT parasite-released factors (PRF), (B) PRF from WT parasites in presence of
indicated antibodies and (C) PRF from WT or TbKHC1 KO parasites, or material purified on anti-PRF antibody affinity column, in presence of indicated
antibodies. Heat treatment was at 45uC for 30 min. Data are means 6 SEM of 3–4 individual mice of one representative from 3 independent
experiments (A, B), or of triplicate cultures of one representative from 2 independent experiments (C). * p,0.05 compared to non-stimulated (-) cells.
doi:10.1371/journal.ppat.1003731.g001
Trypanosoma brucei Kinesin
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TbKHC1 promotes parasite growth in mice by increasing
ornithine availability
In vitro, the parasite growth rate appeared to be identical between
WT, TbKHC1 KD, TbKHC1 KO and TbKHC1-rescued parasites
obtained by reinsertion of the TbKHC1 gene in one allele of its
original locus in the TbKHC1 KO genome (Fig. 4A,B), indicating that
TbKHC1 is not required for parasite growth. Moreover, TbKHC1
KO parasites motility or flagellum movement addressed by
microscopic examination and sedimentation analysis [24] appeared
normal (not shown). TbKHC1 KO parasites were able to perform the
full parasite life-cycle, since procyclic transformants could cycle
through tsetse flies to produce infective metacyclic forms.
In C57Bl/6 mice, the cumulative parasite load in the first peak
of parasitaemia by TbKHC1 KO trypanosomes was reduced by
.70% as compared to WT parasites (Fig. 4C). This reduced
TbKHC1 KO parasite load was also observed under natural
infection conditions in which infected tsetse flies were allowed to
feed on mice (Fig. 4D). Reinsertion of TbKHC1 in TbKHC1 KO
parasites reverted early parasitaemia to WT levels (Fig. S3 in Text
S1).
As compared to infection with WT parasites, at day 7 post-
infection (p.i.) with TbKHC1 KO parasites, spleen myeloid cells
showed a reduced induction of arginase activity that coincided
with increased NO2 accumulation, likely reflecting a shift towards
NOS activity (Fig. 4E,F). Moreover, the induction of arginase
Figure 2. Expression and localization of T. brucei TbKHC1. (A) Detection of TbKHC1 transcripts by Northern blotting of RNA from procyclic
forms (PF), bloodstream (BF) slender (SL) and stumpy (ST) forms, BF TbKHC1 knock-out (KO), overexpressor (OV) and TbKHC1 knock-down (RNAi)
trypanosomes (d: days after doxycyclin induction; ds RNA: double-stranded RNA; histone H2B mRNA: loading control). (B) Detection of TbKHC1 with
anti-rTbKHC1 polyclonal antibody in whole extracts from the indicated trypanosome forms (Tub: Tubulin loading control). (C) Parasite staining with
anti-PRF monoclonal 2C12 antibody. Nucleus (N) and kinetoplast (K) are stained in blue with 49,6-Diamidino-2-phenylindole (DAPI). (D) Localization of
TbKHC1 on WT, KO and OV trypanosomes with anti-rTbKHC1 polyclonal antibody. (E) Immunoprecipitation of TbKHC1, actin, enolase and PDI-2 from
35S-metabolically labelled WT parasite total extracts (1) or supernatants (2).
doi:10.1371/journal.ppat.1003731.g002
Trypanosoma brucei Kinesin
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activity was not observed in infected mice treated with a
neutralizing anti-IL-10R antibody (Fig. 4E). Furthermore, mice
infected with TbKHC1 KO parasites exhibited lower IL-10 serum
levels than mice infected with WT parasites (Fig. 4G). The
reduction of IL-10 secretion in TbKHC1 KO-infected mice could
account for the higher inhibition of arginase activity observed in
the presence of anti-IL-10R antibodies in these mice (Fig. 4E).
In TbKHC1 KO-infected mice, it is unlikely that the reduction
of the first peak of parasitaemia resulted from increased NO
production. Indeed, inhibition of NOS activity by N-(G)-nitro-L-
arginine methyl ester (L-NAME) or absence of iNOS activity in
iNOS KO mice did not affect TbKHC1 KO parasitaemia, while it
strongly reduced WT parasitaemia (Fig. 5A,B). The lower
parasitaemia in TbKHC1 KO-infected mice might rather result
from reduced arginase activity, which would limit nutrient
availability for the parasite. Indeed, this enzyme converts L-
arginine to L-ornithine, a precursor of polyamines that are
required for trypanosome growth [13]. Accordingly, in mice
Figure 3. Mechanism of arginase activity induction by T. brucei PRF and rTbKHC1. Myeloid cells from non-infected WT (A-D,F, G) or IL-4Ra
KO (E) mice were incubated with PRF or rTbKHC1. (A) IL-10 production induced by PRF. (B) Arginase activity induced by PRF incubated with indicated
antibodies or sugars. (C) Arginase activity and IL-10 secretion induced by rTbKHC1 incubated with indicated antibodies or sugars. (D–G) Relative
expression level of M2 genes after incubation with rTbKHC1. In F, M2 IL-10-dependent genes are indicated, and in G, rTbKHC1 was incubated with
the indicated antibodies. Data are means 6 SEM of 3 individual mice of one representative from 3 independent experiments. * p,0.05 compared to
non-stimulated (-) cells.
doi:10.1371/journal.ppat.1003731.g003
Trypanosoma brucei Kinesin
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lacking arginase-1 in myeloid cells/macrophages following a cross
between Arg1 loxP-targeted mice and LysMCre or Tie2Cre deleter
mice [21], WT parasitaemia dropped to that of TbKHC1 KO
parasitaemia (Fig. 5C,D). Moreover, treatment of mice with L-
ornithine increased the cumulative parasite load to a greater extent
in TbKHC1 KO- than in WT-infected mice (,94% vs ,43%,
respectively; Fig. 5E). In addition, spermine levels tended to
increase although without reaching statistical significance in spleen
myeloid cells and blood from mice infected with WT but not
TbKHC1 KO parasites (Fig. S4A in Text S1). Furthermore, an
Figure 4. Effects of TbKHC1 on T. brucei growth and infection in mice. (A,B) In vitro parasite growth (A: monomorphic trypanosomes, either
WT or induced and non-induced TbKHC1 KD; B: pleomorphic trypanosomes, either WT or TbKHC1 KO and rescued TbKHC1 KO). Data are means6 SEM
of one representative from 3 independent experiments (C,D) Parasitemia in C57Bl/6 mice infected with pleomorphic WT and TbKHC1 KO parasites (C:
intraperitoneal injection; D: injection through the bite of infected tsetse flies). Data are means 6 SEM of 4 individual mice of one representative from
6 independent experiments. * p,0.05 comparing TbKHC1 KO- and WT-infected mice. (E–G) TbKHC1-mediated myeloid cell activation. At day 6 p.i.
with WT and TbKHC1 KO parasites, mice were treated with anti-IL-10R (anti-IL-10R Ab) or control antibody (Ctrl Ab), and at day 7 spleen myeloid cells
were analyzed for arginase activity (E), spontaneous NO secretion (F) and IL-10 secretion (G). Data are means 6 SEM of 3 individual mice of one
representative from 3 independent experiments. = p,0.05 comparing WT- or TbKHC1 KO-infected to non-infected mice; £ p,0.05 comparing WT- or
TbKHC1 KO-infected mice treated with anti-IL-10R antibody to WT- or TbKHC1 KO-infected control antibody-treated mice; # p,0.05 comparing
TbKHC1 KO- and WT-infected mice treated with control antibody.
doi:10.1371/journal.ppat.1003731.g004
Trypanosoma brucei Kinesin
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Figure 5. Effects of TbKHC1 on T. brucei parasitaemia. WT and TbKHC1 KO parasitaemias were monitored in various mice and conditions: (A) WT
mice treated with L-NAME or D-NAME; (B) iNOS KO and WT mice; (C,D) myeloid cell Arg1 KO mice (KO1= LysMcreArg1-/lox; KO2= Tie2creArg1-/lox) and
controls (Arg1lox/lox); (E,F) WT mice treated with L-ornithine, D-mannose or D-galactose; (G) MMR KO and WT mice; (H) SIGN-R1 KO and control (Ctrl)
mice. Data are means 6 SEM of 4 individual mice of one representative from 3 independent experiments. * p,0.05 comparing D-NAME and L-NAME
treated mice (A) or WT and iNOS KO mice (B) infected with WT parasites; = p,0.05 comparing Arg1lox/lox and LysMcreArg1-/lox or Tie2creArg1-/lox mice
infected with WT parasites; # p,0.05 comparing L-ornithine treated and non treated mice infected with TbKHC1 KO parasites; ¥ p,0.05 comparing D-
mannose and D-galactose-treated mice infected with WT parasites; £ p,0.05 comparing SIGN-R1 KO and control mice infected with WT parasites.
doi:10.1371/journal.ppat.1003731.g005
Trypanosoma brucei Kinesin
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increase in L-ornithine production, coinciding with the consump-
tion of L-arginine and the induction of N-acetylputrescine
production, was observed in the supernatant of myeloid cells
from non-infected mice activated in vitro with rTbKHC1 (Fig.
S4B in Text S1).
The effect of TbKHC1 on parasite growth involves the
myeloid cell receptor SIGN-R1
Since the in vitro induction of arginase activity by PRF and
rTbKHC1 was inhibited by D-mannose (Fig. 3B,C), we treated
infected mice with D-mannose. This treatment reduced WT
parasitaemia to the level of TbKHC1 KO parasitaemia, but did not
significantly affect TbKHC1 KO parasitaemia (Fig. 5F). To follow
up on this in vivo finding and the in vitro observation that arginase
activation by PRF and rTbKHC1 was inhibited by D-mannose as
well as by an antibody recognizing coils of TbKHC1 (Fig. 1B, 3C),
we monitored the course of WT- and TbKHC1 KO-infection in
mice deficient for myeloid cell receptors able to bind both
mannose and peptidic coils, namely MMR (CD206) and SIGN-R1
(CD209b), using appropriate congenic control mice [25–27]. In
MMR KO mice, WT and TbKHC1 KO parasitaemias were not
affected as compared to infection in WT mice (Fig. 5G). In SIGN-
R1 KO animals the differential control of the first peak of
parasitaemia between WT and TbKHC1 KO parasites vanished,
due to the reduction of the WT parasite level to that of TbKHC1
KO parasites (Fig. 5H). Thus, either the absence of SIGN-R1 in
infected mice or the absence of TbKHC1 in the parasite decreased
T. brucei parasitaemia similarly. These data suggested that
TbKHC1 interacts with the SIGN-R1 receptor. To evaluate this
hypothesis, we tested the in vitro activity of rTbKHC1 on myeloid
cells from SIGN-R1 KO mice. In contrast to results obtained with
myeloid cells from control mice, in myeloid cells from SIGN-RI
KO mice rTbKHC1 did not stimulate IL-10 and Arg1 gene
expression (Fig. 6A) and did not increase arginase activity (Fig. 6B).
Conversely, in myeloid cells from MMR KO mice rTbKHC1
induced expression of Il10 and Arg1 genes as in WT mouse
myeloid cells (Fig. S5 in Text S1). Therefore, TbKHC1 appeared
to trigger arginase activity through SIGN-R1-mediated signaling.
TbKHC1 increases liver pathogenicity and reduces host
survival by NO-dependent mechanisms
The survival time of TbKHC1 KO-infected mice was signifi-
cantly prolonged as compared to WT-infected animals (Fig. S6 in
Text S1, Table 1). Death of mice infected with African
trypanosomes is related to systemic inflammatory response
syndrome (SIRS) that causes multiple organ failure [28]. Liver
myeloid cells are critical to the clearance of trypanosomes from the
bloodstream [29], hence maintaining liver integrity is fundamental
to the host’s ability to clear trypanosomes. At day 30 p.i. several
indicators of liver damage differed between WT- and TbKHC1
KO-infected mice: (i) the serum levels of the liver damage marker
alanine aminotransferase (ALT) were lower in TbKHC1 KO- than
in WT-infected mice; (ii) anoxic infarcts were observed in none of
the TbKHC1 KO-infected mice, but in 6 out of 8 WT-infected
mice; (iii) lobular and portal mononuclear cell infiltrates were
milder in all TbKHC1 KO- than in WT-infected mice (Table 1,
Fig. 6C). Concomitantly, NO production was higher in TbKHC1
KO- than in WT-infected mice, while IL-10 production was not
induced and similar in all infected experimental groups (Fig. 6D).
A moderate increase in iNOS mRNA expression level was also
observed in myeloid cells from mice infected with TbKHC1 KO
parasites (4.261.5 vs 1.3260.33 fold in mice infected with WT
parasites, n = 3; p = 0.08). These data suggested that increased NO
production protected liver integrity in TbKHC1 KO-infected mice.
Accordingly, L-NAME treatment or knock-out of iNOS activity in
TbKHC1 KO-infected mice reduced the survival time and
increased ALT levels to those found during WT parasite infection
(Table 1). L-NAME treatment or absence of iNOS activity in WT-
infected mice did not affect the survival time, although it reduced
the serum levels of ALT (Table 1). Therefore, a threshold of NOS
activity, achieved in TbKHC1 KO- but not in WT-infected mice,
might be required during T. brucei infection to protect liver
integrity, thereby contributing to extended host survival. This
hepatoprotective effect of NO was not due to difference in parasite
load in mice infected with WT and TbKHC1 KO parasites (Fig. S7
in Text S1).
The survival times and ALT levels in WT and TbKHC1 KO-
infected mice were similar in Arg1-deficient mice and control mice
(Table 1). However, treatment of WT-infected mice with L-
ornithine slightly increased the serum level of ALT, while in
TbKHC1 KO-infected mice L-ornithine treatment reduced the
survival time and increased ALT levels to those found during WT
parasite infection (Table 1). Therefore, L-ornithine as a polyamine
precursor favored the development of liver injury and negatively
affected the survival of T. brucei-infected mice.
As in the liver, brain injury characteristic of African trypano-
somiasis was also lower in TbKHC1 KO- than in WT-infected
mice. Indeed, no parasites could be detected in the choroid plexus
of TbKHC1 KO-infected mice, sharply contrasting with the
presence of numerous parasites, associated with immune infil-
trates, in the choroid plexus of WT-infected mice (Fig. S8 in Text
S1).
The survival times as well as ALT, NO and IL-10 levels in WT-
and TbKHC1 KO-infected mice were similar in SIGN-R1 KO and
control mice (Table 1, Fig. 6E), suggesting that in late infection
TbKHC1 signaling no longer operates primarily through SIGN-
R1.
Discussion
We report that a particular isoform of the large KHC family of
T. brucei is released by the trypanosome and influences both
parasite growth and host pathogenicity.
T. brucei contains 51 sequences encoding kinesin-like proteins.
The T. brucei isoform described here appears to be an orphan
member without predicted function [30]. That a KHC isoform
could be released in the extracellular environment is not
unprecedented, since a KHC-like protein has been reported as
secreted from the coagulating gland in rat [31]. TbKHC1 did not
appear to be contained in high molecular weight complexes
released from the parasite, for instance in exosomes as occurs in T.
cruzi [32] and Leishmania [33]. Our immunoprecipitation data,
rather, suggested that TbKHC1 is free in the medium, but the
mechanism of release remains unclear.
TbKHC1 did not appear to be essential for T. brucei cellular
proliferation or differentiation.
In vitro, TbKHC1 triggered arginase activity and, in contrast to
the other documented T. brucei immunomodulators VSG, DNA or
TSIF [9,10,12], inhibited NO synthesis by myeloid cells. These
effects involved a region rich in coils in the TbKHC1 C-terminal
domain, since they were inhibited by an antibody specifically
recognizing the coiled region of TbKHC1.
Arg1 is often recognized as a prototypic M2 myeloid cell marker
induced following STAT6 activation by IL-4/IL-13/IL-4Ra
signaling. However, Arg1 can be expressed by M1 cells in a
STAT3-dependent pathway triggered by IL-10, IL-6 and G-CSF
[21,23]. In agreement, rTbKHC1 induced the expression of Il10
Trypanosoma brucei Kinesin
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Figure 6. SIGN-R1 receptor contribution to myeloid cell activation and liver injury. (A,B) Effects of rTbKHC1 on myeloid cells from non-
infected control (Ctrl) or SIGN-R1 KO mice (A: relative expression of Arg1, Arg2, Il10 and iNOS genes; B: arginase activity in presence of indicated
antibodies or sugars). Data are means 6 SEM of 3 individual mice of one representative from 3 independent experiments. * p,0.05 compared to
non-stimulated (-) cells. (C) Effects of rTbKHC1 on liver injury: microscopic analysis (hematoxylin-eosin staining, magnification 206) of sections from
WT- and TbKHC1 KO-infected mice at day 30 p.i. Anoxic infarcts (ai), periportal (..) and lobular (.) mononuclear cell infiltrates were representative
of 8 animals tested in 2 independent experiments. (D) Spontaneous NO and IL-10 secretions in spleen myeloid cell supernatants from WT- and
TbKHC1 KO-infected mice treated with D-NAME or L-NAME (day 30 p.i.). (E) Idem as D in SIGN-R1 KO and control (Ctrl) mice. Data are means6 SEM of
3–4 individual mice of one representative from 3 independent experiments. = p,0.05 comparing WT or TbKHC1 KO- infected mice to non-infected
mice; £ p,0.05 comparing L-NAME and D-NAME treatment in WT- or TbKHC1 KO-infected mice; # p,0.05 comparing WT- and TbKHC1 KO-infected
mice.
doi:10.1371/journal.ppat.1003731.g006
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and Il6 genes in myeloid cells, and this neither involved IL-4Ra
nor induced the expression of genes associated with M2 activation.
Since Il6 expression was still induced in the presence of the Arg1
expression inhibitor anti-IL-10R antibody, we conclude that
rTbKHC1-induced Arg1 expression primarily depended on IL-
10 production.
In mice, TbKHC1 activity appeared to promote parasite
growth in the early stage of infection. Reduced parasitaemia
induced by TbKHC1 KO trypanosomes was associated with
increased NO production, but did not directly result from this
increase. Indeed, inhibition of NO production by L-NAME
treatment or in iNOS KO mice did not improve TbKHC1 KO
growth. Rather, in agreement with previous studies [34] L-NAME
treatment or absence of iNOS activity in mice actually increased
the control of WT parasitaemia. Together, these experiments
suggested that the negative/braking effect of NO on the control of
WT parasitaemia requires the expression/activity of TbKHC1.
We propose that TbKHC1-mediated induction of host arginase
activity fuels L-ornithine production and hereby the synthesis of
polyamines, which are essential nutrients for growth of extracel-
lular trypanosomes in the host. In bloodstream forms of T. brucei
the arginase gene and activity are absent, but when exogenous L-
ornithine is lacking in body niches these parasites can use L-
arginine to produce L-ornithine through an arginase-independent
mechanism [35,36]. However, the differential growth-promoting
effect of exogenous L-ornithine during infection by WT or
TbKHC1 KO parasites suggests that this arginase-independent
mechanism is insufficient to provide all the amines necessary for
the polyamine pathway. Similarly, the related but intracellular
parasite Leishmania also requires host arginase induction for
optimal growth, despite the presence of an arginase gene [37].
Therefore, optimal production of L-ornithine/polyamines for T.
brucei growth would rely on host arginase activity induced by
TbKHC1. In accordance, in two models of mice deficient for
arginase-1 in myeloid cells/macrophages, WT T. brucei growth was
reduced to the level observed with TbKHC1 KO parasites.
In T. brucei-infected mice, the TbKHC1-mediated effect on
parasitaemia appeared to involve the myeloid cell receptor SIGN-
R1. Indeed, improved parasite growth control was observed after
either removal of TbKHC1 from the parasite or removal of
SIGN-R1 from the host. Moreover, rTbKHC1-mediated induc-
tion of arginase activity was lost in myeloid cells from SIGN-R1
KO mice. The involvement of SIGN-R1 in TbKHC1-mediated
IL-10 and arginase production is in keeping with previous data
demonstrating the anti-inflammatory role of SIGN-R1 in various
diseases [38–40]. Although LPS and intracellular mycobacteria
infection can induce Arg1 in a MyD88/IL-10 dependent manner
[21,23], we can exclude that TbKHC1 is simultaneously a ligand
for SIGN-R1 and a trigger for MyD88 signaling in our
extracellular infection model since the differential infection
phenotype between WT and TbKHC1 KO T. brucei was conserved
in Myd88 KO mice (data not shown).
D-mannose was found to decrease parasite growth during the
first peak of parasitaemia by WT but not TbKHC1 KO parasites,
and it inhibited rTbKHC1-mediated induction of IL-10 and
arginase by myeloid cells. Similarly, the 2C12 antibody, which is
specific to the coiled region of TbKHC1, inhibited IL-10
production and arginase activity triggered by rTbKHC1. Man-
nose-specific receptors such as SIGN-R1 and MMR are known to
interact with coiled proteins, the complement protein C1q and
collagen respectively [26,27]. Therefore, it is possible that
mannose binding to SIGN-R1 could affect the binding of
TbKHC1 peptidic coils to a second binding site of this receptor.
After the parasite growth-promoting effect occurring during the
first peak of parasitaemia, a distinct effect of TbKHC1 consisted in
reducing the survival time of infected mice while contributing to
liver injury. Given the similar in vitro growth properties between
parasites expressing or not TbKHC1, the mechanism by which
this protein influenced the host survival time is likely to be
independent from differences in parasite virulence. Parasite load
throughout the infection, survival and pathogenicity are indepen-
dent traits in experimental and natural infection with African
Table 1. Survival and liver pathology in T. brucei WT- and TbKHC1 KO- infected mice.
Mice Survival time (days, Mean ± SEM) # animals tested ALT (day 30 p.i.) (U/ml, Mean ± SEM) # animals tested
WT TbKHC1 KO WT TbKHC1 KO
D-Name treated 4266.1 79610* 11 753695 80669* 12
L-Name treated 4565.1 4665.6£ 15 3446120£ 216651£ 12
iNOS control 4268.0 83615* 6 6186124 110669* 6
iNOS KO 38614 4266.1£ 6 494699 545653£ 6
Untreated 4269.0 66612* 24 783665 94679* 15
L-Ornithine treated 4066.9 4663.9£ 12 6496123 325645£ 12
Arg1 controla 3564.8 74610* 12 8086316 1956177* 4
LysMcreArg1 KOb 3764.4 71613* 7 8526142 2706146* 4
Tie2creArg1 KOc 3967.6 7669.5* 8 11306295 160680* 4
MMR control 3762.3 69618* 6 5556234 1936173 6
MMR KO 43611 59611 6 5586111 1456114* 6
SIGN-R1 control 38610 81618* 9 10106300 270610* 6
SIGN-R1 KO 2966.0 95612 13 7456187 360650£ 6
aArg1lox/lox mice;
bLysMcreArg1-/lox mice;
cTie2creArg1-/lox mice.
*p,0.05 comparing TbKHC1 KO- and WT- infected mice ;
£p,0.05 comparing treated and control treated infected mice.
doi:10.1371/journal.ppat.1003731.t001
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trypanosomes [2,4,6–8,28]. Therefore, the survival time difference
between WT- and TbKHC1 KO-infected mice is primarily due to
differences in tissue damage inflicted by inflammatory immune
responses, rather than differences of parasite load in the first peak
of parasitaemia. NO contributes to peripheral pathogenicity
induced by African trypanosomes, while IL-10 exerts counter-
pathogenic activity [2,3]. In late stages of infection, IL-10
production was unaffected by the absence of TbKHC1, while
NO production (and iNOS expression) was lower when TbKHC1
was present. Moreover, the reduction of liver injury in TbKHC1
KO-infected mice was erased by inhibition of NO synthesis upon
L-NAME treatment or by infecting iNOS KO mice. Thus,
TbKHC1-mediated depletion of NO might contribute to the
liver damage associated with WT parasite infection. Accordingly,
NO plays a pivotal role in vascular tone, and decreased NO
bioavailability contributes to pathogenesis in chronic infectious
diseases like malaria, and in liver ischemia reperfusion injury
[41,42]. Our observation that after the first peak of parasitaemia
parasite load was similar in WT- and TbKHC1 KO -infected mice,
even upon inhibition of NO production, supports the notion that
blood parasite load is not a major contributor to liver pathoge-
nicity.
Besides NO, polyamines contribute to the pathogenicity of T.
brucei infection [43]. Since our data suggest that induction of
arginase activity by TbKHC1 could sustain the production of
polyamines, these molecules could contribute to increase liver
injury in WT- as well as in TbKHC1 KO-infected mice fed with L-
ornithine.
In the late stage of infection, the effects of TbKHC1 did not
appear to depend on SIGN-R1 any longer, since the absence of
SIGN-R1 did not affect the survival time and liver injury in WT-
and TbKHC1 KO-infected mice. A major difference between early
and late infection is the evolution of the immune response driven
by the continuous release of immunomodulatory/inflammatory
factors by the parasite, such as VSG and TSIF, which induce
pathogenic TNF-a and IFN-c [1,4,9] while switching off the IL-10
production [7]. The evolving context of host-parasite interaction
could affect TbKHC1 signaling, and indeed the myeloid cell
activation state and corresponding expression of receptors is
known to vary during the time course of T. brucei infection [44].
Therefore, we cannot exclude that in infected SIGN-R1 KO mice,
compensation by other myeloid cell receptors influences the
immune response and outcome of pathogenicity in the late stage of
the disease.
In conclusion, we have identified an unexpected function for a
KHC of extracellular T. brucei, which is SIGN-R1-mediated
activation of myeloid cells to produce IL-10 leading to increase in
arginase activity, resulting in promotion of parasite growth in the
host.
Methods
Ethic statement
Experiments, maintenance and care of mice complied with
guidelines of the European Convention for the Protection of
Vertebrate Animals used for Experimental and other Scientific
Purposes (CETS nu123) and were approved by the Ethical
Committee for Animal Experiments of the Universite´ Libre de
Bruxelles, Brussels, Belgium (laboratory accreditation number
LA2500482).
Mice, trypanosomes and infection protocol
WT C57Bl/6 mice were from Harlan, iNOS KO C57Bl/6 mice
from Jackson Laboratory. MMR KO, IL4Ra KO, control Arg1lox/lox,
LysMcreArg1-/lox and Tie2creArg1-/lox mice (C57BL/6 background),
SIGN-R1 KO and congenic control mice (BALB/c background) were
bred in-house.
T. brucei bloodstream monomorphic ‘‘single-marker’’ [45] and
pleomorphic AnTat 1.1E (EATRO1125 strain) were used.
Mice were infected i.p. with 2,000 AnTat1.1E parasites [6].
Parasitaemia was monitored by tail blood puncture. When
required, mice were injected i.p. 2 h before infection with 2 mg
L-NAME, then 1 mg/ml L-NAME was added to drinking water.
The less active enantiomer D-NAME was used as control. For L-
ornithine treatment, mice received 2 mg i.p. 2 h before infection,
and then were given 5 mg/ml in drinking water. For D-mannose
or D-galactose treatment, mice received 50 mg i.p. 2 h before
infection, then every 2 days. Sugar treatment caused massive
inflammation and the animals were euthanized 12 days p.i. To
neutralise IL-10 activity, mice were treated once with 200 mg
control antibody (rat IgG1, BD Biosciences) or 1B1.3a anti-IL-
10R antibody at day 6 p.i. Injections of anti-IL-10R antibody at
day 2, 4 and 6 p.i. killed WT- and TbKHC1 KO- infected mice
within 48 h, as reported [6].
Parasite released factors, antibodies and PRF
immunoaffinity column
PRF was prepared as described [15]. Monoclonal antibodies
were obtained following an immunoenzymatic screening that
selected antibodies directed against PRF, followed by a test based
on inhibition of arginase activity induction. rTbKHC1 C-terminal
fragment was used for production of rabbit polyclonal antibodies.
PRF was incubated overnight with 2C12 monoclonal antibody
coupled to Sepharose 4B CNBr resin at 4uC in carbonate buffer
(v/v). After loading on a column and washings, bound material
was eluted with glycine-HCl (pH 3), then glycine-NaOH (pH 10),
dialysed for 24 h against milliQ water, lyophilised and solubilized
at 1 mg/ml in 50 mM phosphate buffer, 1 M NaCl (pH 6.2). The
residual level of endotoxins was below 2 U/mg (LAL assay,
Biowhittaker).
cDNA expression library screening
Approximately 105 plaques from a bloodstream T. b. gambiense
LiTat1.3 cDNA expression library (lambda ZAP express, Strata-
gene) were screened by incubation with the mouse 2C12
monoclonal antibody. Clones targeted by an anti-mouse anti-
body/alkaline phosphatase conjugate were identified by incuba-
tion at pH 9.5 with the chromogenic substrate NBT/BCIP.
Reactive clones were plaque purified by 2 additional rounds of
screening. The positive clones were processed to obtain the
circular pBK CMV plasmid version of the phage, according to the
manufacturer instructions.
TbKHC1 KD and KO parasites
For TbKHC1 KD, a 500 bp fragment from the TbKHC1 open
reading frame (ORF) was amplified by polymerase chain reaction
(PCR) using the KD primers (Table S1 in Text S1), digested with
XhoI and BamHI and ligated into the p2T7-177TiTA plasmid [46].
The vector was linearized with NotI and transfected into
monomorphic bloodstream forms. Stable transformants were
selected with 1 mg/ml hygromycin. Double stranded RNA
production was induced by addition of 1 mg/ml doxycyclin. For
TbKHC1 KO parasites, both alleles of the complete TbKHC1 ORF
were replaced in procyclic forms by genes encoding resistance to
neomycin and bleomycin, following transfection of these genes
flanked by 75 bp sequences from the TbKHC1 UTRs. Primers
used for PCR amplification of the resistance genes were KOneo
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and KObleo (Table S1 in Text S1). Stable transformants were
selected with 15 mg/ml geneticin and 2.5 mg/ml phleomycin.
Pleomorphic TbKHC1 KO parasites were obtained by cyclical
transmission of TbKHC1 KO procyclic forms in tsetse flies.
Rescue of TbKHC1 KO parasites
TbKHC1 gene and UTRs were PCR-amplified (Rescue primers,
Table S1 in Text S1) and cloned into pCR-XL-TOPO vector
(Invitrogen). The neomycin resistance cassette was extracted from
pLew114hyg59 [45] with AflII and StuI restriction enzymes and
cloned into the AflII and EcoRV digestion of the pCR-XL-TOPO-
TbKHC1 clones presenting the 59 sequence of TbKHC1 gene
next to the pUC origin. pCR-XL-TOPO-TbKHC1-Neo was
linearized at AvrII and transfected in vivo into TbKHC1 KO
pleomorphic parasites as described [47].
TbKHC1 overexpressing trypanosomes
TbKHC1 ORF was amplified by PCR from the initial pBK-
CMV plasmid clone 4 (primers OV, Table S1 in Text S1) digested
with EcoRV and HindIII, and cloned in the pTSARib vector [48].
The construct was linearized with BglII before transfection.
rTbKHC1
The full length TbKHC1 and a 2,235 bp TbKHC1 fragment were
amplified by PCR from the initial pBK-CMV plasmid clone 4
using primers FL and C-term (Table S1 in Text S1). The products
were digested with SalI and NotI and cloned in-frame in pET 21d
(Novagen). rTbKHC1 was extracted from IPTG-induced E. coli
and purified on Ni-NTA agarose (Qiagen) using 60% isopropanol
in the washing steps to remove endotoxins [49]. The protein was
additionally purified by HPLC Superdex 200 (10/300 GL,
Pharmacia) in 50 mM phosphate buffer, 1 M NaCl (pH 6.2).
The residual level of endotoxins was below 2 U/mg (LAL assay,
Biowhittaker).
Immunofluorescence assay
Fixed parasites (4% formaldehyde in PBS, 10 min, 20uC) spread
on poly(L-lysine)-coated slides were permeabilized (0.1% Triton
X-100 in Tris-buffered saline 5 min, 20uC) and incubated with 5%
BSA. TbKHC1 was detected with the 2C12 monoclonal (dilution
1/200) or rabbit polyclonal (dilution 1/1000) antibodies and Alexa
488-conjugated anti-mouse or anti-rabbit IgG (dilution 1/1000).
Metabolic labelling
Washed trypanosomes were incubated 15 min at 37uC at a
density of 26107 cells/ml in IMDM methionine-free medium
supplemented with 10% FCS, 0.07 mM L-arginine, 0.2 mM L-
glutamine, 0.04 mM L-leucine, 0.1 mM inositol, 0.05 mM D-
glucose, 30 mM Hepes, 1 mg/ml BSA, 0.5 mM adenosine and
5 mg/ml catalase. Then, a mix of 35S-labelled methionine and
cysteine was added (100 mCi/ml). After 1 h labelling, cells were
washed and incubated for 2 h at 37uC at a density of 26106/ml.
Trypanosomes were centrifuged and lysed in 50 mM Tris,
150 mM NaCl, 2 mM EDTA, 1% NP40, complete protease
inhibitors (Roche).
Tomato lectin chromatography
Fractionation of trypanosome extracts on tomato lectin affinity
column was performed as described [16].
Preparation of myeloid cells
Non elicited peritoneal cells were collected in 0.34 M sucrose.
Spleen homogenates were incubated 10 min in cold 0.83%
NH4Cl/0.01 M Tris-HCl, pH 7.2 to lyse erythrocytes. Peritoneal
and spleen cells were washed twice in complete medium (RPMI
1640 supplemented with 10% heat-inactivated FCS, 561025 M
2-mercaptoethanol, 2 mM L-glutamine, 100 IU/ml penicillin,
100 mg/ml streptomycin, and 0.1 mM non essential amino acids;
all from Invitrogen Life Technologies) and counted by trypan blue
exclusion. To prepare myeloid cells, peritoneal cells adjusted to
56106 cells/ml in complete medium were dispensed by 1 ml in 6-
well plates and spleen cells adjusted to 107 cells/ml were dispensed
by 10 ml in 10-cm tissue culture dishes. After 3 h at 37uC in 5%
CO2, cells were washed five times with warm complete medium to
remove non adherent cells. Adherent cells were collected in cold
complete medium using a scraper, washed and viability was
determined by trypan blue exclusion (usually .95%). Cells
(CD11b+ for .90% as determined by flow cytometry, data not
shown) were suspended in complete medium at 106 cells/ml.
In vitro culture of myeloid cells
Peritoneal myeloid cells from non infected mice (56105/ml)
were cultured in 24-well plates in presence of 56105/ml
trypanosomes, 80 mg/ml PRF, 3 mg/ml eluate of anti-PRF
antibody affinity column or 3 mg/ml rTbKHC1. When required,
antibodies (monoclonal anti-PRF, JES5-2A5 anti-IL-10 (BD
Biosciences), 1B1.3a anti-IL-10R or appropriate isotype-matched
antibodies (3 mg/ml), D-mannose or D-galactose (50 mM) were
added to PRF- or rTbKHC1-stimulated cells. Unless specified,
gene expression, arginase activity and NO2 and IL-10 secretions
were determined after 24 h of culture. Alternatively, spleen
myeloid cells from infected mice (106/ml) were collected at day
7 or 30 p.i. and stored for arginase activity determination or
cultured for 24 h before determining spontaneous NO2 and IL-10
production in culture supernatants.
Myeloid cell metabolite extraction, HPLC-MS analysis and
data processing
Spleen myeloid cells prepared as described above were cultured
in modified complete medium (2% FCS, no 2-mercaptoethanol,
no antibiotic) in 24-well plates in presence of 3 mg/ml rTbKHC1.
After 12 h culture, supernatants were collected, rapidly cooled to
4uC in dry ice ethanol bath and centrifuged (3 min, 4uC,
13,000 g). Protein denaturation was achieved by adding 200 ml
of 4uC chloroform:methanol:water (1:3:1) to 5 ml of cell superna-
tants. Samples were shaken for 1 h at 4uC and centrifuged again.
The supernatants were extracted and frozen at 280uC until the
samples were submitted to High Performance Liquid Chroma-
tography-Mass Spectrometry (HPLC-MS) analysis at the Scottish
Metabolomics Facility using High Performance Liquid Chroma-
tography (Dionex UltiMate 3000 RSLC system) with a ZIC-
HILIC 15064.6 mm, 5 mm columns (Merck Sequant). The
mobile phase comprised 0.1% formic acid in water (phase A)
and 0.08% formic acid in acetonitrile (phase B). A linear gradient
was applied to B from 80-20% over 30 minutes, followed by an
8 minute wash with 5% B and concluded with 8 minute
equilibration with 80% B. The flow rate was 300 mL/min and
10 mL was injected into the column. The column temperature was
20uC and the autosampler temperature was 4uC.
For data processing, LC-MS raw data were processed using
IDEOM software (version 17) [50] which is a composite of XCMS
[51], mzMatch [52], R and Microsoft Excel packages. Firstly,
XCMS detected peaks with a peak width between 10 and
100 seconds; signal to noise ratio of 5 and mass deviation between
scans of 2 parts per million (ppm). MzMatch then matched the
peaks between the two samples, comparing their retention times
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(RT) and ion densities before calculating any deviations. Peaks
were identified according to their mass-to-charge ratio and RT.
Arginase activity, NO2 and IL-10 secretion, spermine
levels
Arginase activity was determined as described [53]. NO2
quantification (reflecting NO production) was assayed by a Griess
reaction. IL-10 was quantified with a specific sandwich ELISA
(PharMingen) in accordance to the manufacturers’ protocols.
Spermine levels (Spermine ELISA Kit, Antibodies-online) were
determined in blood serum and myeloid cell homogenates
following the manufacturers’ protocols.
Gene expression analysis
Quantitative real time PCR was performed as described [6].
Results of the PCR analyses were normalized against the house-
keeping gene S12. Primers used are described in Table S2 in Text
S1.
Microscopy, ALT levels
Brains and livers were fixed in 4% formaldehyde. Histological
sections embedded in paraffin were stained with hematoxylin-
eosin-saffron for microscopic evaluations. ALT was measured in
serum samples using commercially available kits (Boehringer
Mannheim).
Cumulative parasitaemia load, statistical analysis
GraphPad Prism 4.0 software was used to determine the
cumulative parasitemia load (Area Under Curve function) and the
statistical significance (Two-way ANOVA).
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